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INTRODUCTION
Incontinentia pigmenti (IP) is a rare X-linked genoderma-
tosis and is also called ‘Bloch-Sulzberger syndrome’ (1, 2). Mu-
tation of NEMO/IKKr gene in Xq28 is believed to play a
role in pathogenesis and it occurs mostly in female infants
due to its fatality in male in utero (1, 2). Skin manifestation
is the earliest symptom and is classified as 3 or 4 stages such
as vesicular, verrucous, hyperpigmented, and sometimes hy-
popigmented stage (2, 3). Other accompanying diseases are
dental, ocular, auricular, central nervous system (CNS), mus-
culoskeletal, and cardiovascular anomalies of different severi-
ties (2-4).
We investigated clinical symptoms, disease onset, and ac-
companying disorders in 40 cases of IP by reviewing their




We have reviewed 64 cases of IP who visited or were re-
ferred to dermatologic clinic of Seoul National University
Hospital or Chung-Ang University Hospital from June 1995
to May 2005. Total 24 cases were excluded by their incom-
patibility or lack of evidences supporting diagnostic criteria
of IP set by Landy and Donnai (3). Therefore, 40 cases were
included in this study. The study was approved by the Insti-
tutional Review Board of the Seoul National University Hos-
pital.
Data collection
Medical records of neonatal data as well as inpatient and
outpatient charts, clinical photographs, biopsied sample slides,
laboratory results, skeletal radiographs, and telephone survey
of all affected patients were reviewed by two experienced der-
matologists. Information included sex, disease onset, skin stage
at the time of diagnosis, distribution of skin lesions, eosino-
philic count in peripheral blood analysis, and whether to have
neurologic anomalies, dental defects, oculopathies, and other
accompanied disorders. 
Clinical stages
From the medical records and clinical photographs of the
skin lesions, clinical stages were checked as 1st vesicular, 2nd
verrucous, 3rd hyperpigmented, and 4th hypopigmented
stage to identify whether their time of initial diagnosis were
being made early or not (Fig. 1). 
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Incontinentia Pigmenti: Clinical Observation of 40 Korean Cases 
Incontinentia pigmenti (IP) is an uncommon genodermatosis that usually occurs in
female infants. It is characterized by ectodermal, mesodermal, neurological, ocular,
and dental manifestations. The aim of this study was to clarify clinical symptoms,
accompanying diseases, and complications of IP. Forty cases of IP have been re-
viewed by their medical records, laboratory data, clinical photographs, and telephone
survey. Male-to-female ratio was 1 to 19 and their onsets were mostly in utero. They
were usually diagnosed during the neonatal period owing to their early expression
of skin manifestation. Central nervous system anomalies were found in 46.7%. Ocu-
lar disorders and dental defects were detected in 66.7% and 72.7% respectively.
The most commonly diagnosed anomalies were hypodontia, retinopathy, and sei-
zure. For better understanding of IP, long term and close cooperation between der-
matologists, pediatricians, neuroscientists, genentic counselors, and even dentists
is crucial.
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RESULTS
Sex ratio and disease onset
Among 40 cases of IP, only 2 cases (5%) were males and
the others were females. The onset of disease has been classi-
fied as inborn, neonatal, infant, and early childhood. Disease
of onset has been marked as ‘since born’ when patient showed
skin symptom inborn, ‘neonatal’ within 4 weeks since birth,
‘infant’ 1 month to 12 months, and ‘early childhood’ from 1
yr to 6 yr old. The most common period of disease onset was
inborn 67.5% (27 cases), and neonatal period 17.5% (7 cases),
infant 10% (4 cases), early childhood 5% (2 cases) in order. 
Clinical stages
Clinical stage at the time of initial visit has been analyzed.
Vesicular stages were 52.5% (21 cases), verrucous stages 30%
(12 cases), hyperpigmented stages 15% (6 cases) and hypopig-
mented stages 2.5% (1 case), respectively. And there was no
patient whose initial visit was at stage 4. Therefore, initial
visit of the patients were made relatively early clinical stages
in more than half of cases (Table 1). 
Distribution of skin lesions
Skin lesions were widely distributed and involved the whole
body in 20% (8 cases). In 37.5% (15 cases), skin lesions were
found in whole body except face. Involvement of only trunk
and lower extremities was 17.5% (7 cases). In only 1 case,
skin lesions were limited only in trunk. 
Distribution of the skin lesions were also evaluated by ana-
tomic area. Lower extremities (97.5%, 39 cases) were the most
common site of involvement and trunk (77.5%, 31 cases),
upper extremities (57.5%, 23 cases), face (20%, 8 cases) in
order. 
Eosinophilia
Among 40 cases, blood eosinophilia was not checked in 17
cases. In 23 evaluated cases, blood eosinophilia has been de-
tected in 47.8% (11 cases) at least one of serial checks during
follow-up periods. 
Accompanying diseases
Thirty cases were evaluated for their CNS anomalies by sei-
zure history, brain CT, brain MRI, and electroencephalogram.
The other 10 cases free from objective symptom were not
checked for neurologic anomalies. CNS anomalies of various
severities were detected in 46.7% (14 cases). Seizure (57.1%,
8 of 14 cases) was the most common CNS related symptom
and followed by ataxia and sphingoencephalitis.
Ocular anomalies were evaluated from medical chart records,
fundoscopy, and slip lamp examination. Twenty four cases
were evaluated for their oculopathies and 66.7% (16 cases)
of them presented anomalies or ocular disorders. Retinopa-
thy (56.3%, 9 cases) was the most common oculopathy and
the next was strabismus (31.3%, 5 cases).
Twenty two cases were examined for their dental anoma-
lies and 72.7% (16 cases) showed defects or anomalies in den-
tal system. Hypodontia (43.8%, 7 cases) was the most com-
mon dental anomaly and the next was delayed eruption of
teeth (37.5%, 6 cases).
DISCUSSION
IP is a rare genodermatosis and its prevalence in general is
about 1 per 40,000 (3). More than 95% of the patients are
female infants because it may be fatal when it occurs in male
fetus (4, 5). In this study, affected male infants were also found
in two cases. Affected male infant who survived may have a
Fig. 1. Clinical stages of incontinentia pigmenti. (A) Linear vesicles and bullae of stage 1. (B) Dark brown colored verrucous papules
and plaques of stage 2. (C) Light brown colored swirling hyperpigmentation of stage 3. (D) White atrophic patches of stage 4.
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potential possibility of Klinefelter syndrome (1, 6, 7). Unfor-
tunately, we were not able to perform chromosomal studies
due to refusal of further genetic studies by parents of the male
patients. Skin lesions may follow Blaschko lines and their
melanoblasts start to transform into melanocytes after birth
(8, 9). Initial appearance of skin manifestations can be obser-
ved at birth or within neonatal period. Therefore, the role of
dermatologists and pediatrician is crucial in early diagnosis
of IP. Skin manifestation of stage 1 usually presents within
2 weeks after birth and it may disappear within 4 months
in 90% of cases (5). Skin lesions of stage 2 can be identified
within 2 months and disappear within 6 months after birth
(3, 5). In this study, 82.5% of the cases presented skin lesions
of stage 1 or 2 at birth or within 1 month after birth, which
was similar to the results of the studies by Carney (70-90%)
(5) and Hadj-Rabia et al. (80-92%) (10). So, diagnosis of IP
in Korea is considered to be made as soon as skin manifesta-
tion presents. But, hypopigmented patches of stage 4, which
are important clues of diagnosis of IP (11), were not found
in this study due to young ages of the cases.





1 F birth 2 - seizure retinopathy hypodontia -
2 F infant 1 - cerebral palsy retinopathy ND DD, bronchopneumonia
3 F neonate 2 - - retinopathy DE -
4 F birth 1 + leukomalacia retinopathy ND ND
5 F birth 1 ND ND ND ND ND
6 F infant 3 ND ND ND ND ND
7 F early childhood 3 ND cerebral palsy strabismus hypodontia DD, candidiasis
8 F birth 1 + seizure retinopathy ND DD
9 F neonate 1 - - myopia - UTI
10 F birth 2 - cerebral palsy ND ND ND
11 F birth 1 ND - strabismus - -
12 F birth 1 ND ND ND ND ND
13 F birth 1 ND - ND - -
14 F neonate 2 ND - ND - -
15 F infant 3 ND ND ND ND ND
16 M birth 1 + - - hypodontia DE PDA, congenital
megacolon, hernia
17 F early childhood 3 - - - - -
18 F birth 1 - cerebral palsy - ND -
19 F birth 2 - ND ND ND -
20 F birth 1 + ND ND ND ND
21 F birth 1 + hemiplegia retinopathy, microphthalmia ND -
22 F neonate 2 + ND ND ND ND
23 F birth 1 ND ND ND ND ND
24 F birth 1 ND seizure, hemiplegia retinopathy ND -
25 F birth 3 ND seizure, encephalitis - DE DD
26 F infant 4 ND - hypermetropia hypodontia -
27 F birth 2 + - ND ND PDA, VSD
28 F birth 2 - - ND ND ND
29 F birth 2 - - retinopathy, aphakia hypodontia, DE alopecia, 1st degree
AV block
30 F neonate 1 + seizure - - deafness
31 M birth 1 - seizure - - bronchiolitis
32 F birth 2 ND ND ND ND ND
33 F birth 2 ND - strabismus hypodontia, MC -
34 F birth 1 + infantile spasm retinopathy - -
35 F neonate 3 - - strabismus MC -
36 F birth 1 ND - - DE -
37 F birth 1 ND - - MC,  DE -
38 F birth 2 + seizure strabismus DE -
39 F birth 1 + - ND DE -
40 F neonate 1 ND ND ND ND ND
Table 1. Summary of patients with Incontinentia pigmenti 
W, whole body; H, head and neck; T, trunk; UE, upper extremities; LE, lower extremities; DD, developmental delay; DE, delayed eruption of teeth; UTI,
urinary tract infection; PDA, patent ductus arteriosus; VSD, ventricular septal defect; MC, malformed crowns; ND, not done.Incontinentia Pigmenti in Korea 477
Existence of blood eosinophilia is also a diagnostic clue espe-
cially in neonatal period. Blood count of eosinophils gradually
decreases without invading internal organs as the patient grows
up (12). In addition, severity of skin lesion has no significant
relation with blood count of eosinophils (3, 13). In this study,
presence of eosinophilia was identified only in 47.8% of 23
cases who had serial blood checks during neonatal periods. 
Anomalies of other organs especially CNS, dental, and ocu-
lar systems should be also evaluated. Oculopathies of variable
severities that can be identified in more than 1/3 of the IP
cases include speckled diffuse hypopigmentation in the reti-
na, which is the pathognomonic finding of IP, microphthal-
mia, lenticular hemorrhage, retrolental fibroplasia, cataract,
and atrophy of the optic nerve (1, 5). Dental anomalies are
found in 65-90% of IP cases and they are usually delayed
eruption of teeth, changes in dental contour (circular or coni-
cal shape), and hypodontia (1, 4, 5). CNS related disorders
such as seizure, microcephaly, mental retardation, and spas-
tic paralysis may be detected in 10-40% of the cases (1, 2, 5).
In this study, percentages of oculopathies (66.7%) and CNS
anomalies (46.7%) were relatively higher than those of pre-
vious Western reports (1-5). The percentages of dental defects
were slightly lower when it was compared with previous We-
stern reports (1-5). We do not know the reason of different
rates in ocular, dental, and CNS diseases between IP cases of
Western and Korean studies. However, accessibility of den-
tal care by this study population may partially explain these
differences. Dental hospitals or dental clinics are not easily
accessible by patient referral system which is requested by
dermatologists or pediatricians. Another possible explanation
is that dentists are not so much familiar with IP as physicians
so that they may ignore minor anomalies and do not record
them in medical records. 
Compared with previous Korean IP study report by Chun
et al. (14), accompanying anomalies were markedly increased
and more specified in our study. These diverse anomalies might
result from the growth of social-economic status, increased
familiarity of physicians due to studies and researches related
with genetic diseases, and long term cooperation between
physicians of many different specialties such as dermatology,
pediatrics, dentistry, neurology, and genetics. Anomalies may
not appear at the initial evaluation but continuing work-up
and long term precise follow-up using referring system may
increase the detection rate of potential anomalies which may
occur in early childhood or later. Therefore, long term and
close cooperation between dermatologists, pediatricians, neu-
rologists, genetic counselors, and even dentists is crucial for
better understanding of IP and prediction of occurrence of
potential anomalies in the later life.
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